Loading organizations...
Quan Capital is a global venture capital firm focused on healthcare, investing in and nurturing life sciences companies. It targets early and growth-stage startups in pharmaceuticals, biotechnology, and healthcare. The firm uses a unique investment approach to back disruptive solutions advancing medical treatment.
Founded to capitalize on dynamic life sciences opportunities, the firm bridges innovation across biopharmaceutical markets. With bases in China and the United States, Quan Capital identifies and cultivates promising ventures, driving therapies and technologies.
Quan Capital partners with innovative life sciences entrepreneurs developing therapeutic, diagnostic, and health technology solutions. Its long-term vision is to accelerate medical advancements through capital and support, enhancing global patient care and fostering future healthcare innovation.
Key people at Quan Capital.
Quan Capital was founded in 2017 by Samantha DU (Founder & Managing Director).
Quan Capital has 12 tracked investments across 11 companies. The latest tracked deal is $60.0M Series B in Avenzo Therapeutics in September 2025.
Key people at Quan Capital.